LANJIAN(SH:688557)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥154,384,813.79, representing a year-on-year increase of 31.07%[2] - The net profit attributable to shareholders was -¥730,872.67, with a significant increase in losses compared to the previous year[2] - The net cash flow from operating activities was -¥50,845,983.69, indicating a decline in cash generation[2] - Total operating revenue for Q1 2023 was ¥154,384,813.79, an increase of 31.0% compared to ¥117,786,787.91 in Q1 2022[13] - Net loss for Q1 2023 was ¥730,872.67, a significant improvement from a net loss of ¥3,575,997.14 in Q1 2022, representing a reduction of 79.6%[14] - The company reported a total profit loss of ¥3,239,012.07 in Q1 2023, an improvement from a loss of ¥5,677,370.03 in Q1 2022[14] Cash Flow and Liquidity - The company's cash and cash equivalents were reported at ¥131,041,941.81, down from ¥159,249,505.68, a decline of about 17.7%[9] - Cash flow from operating activities for Q1 2023 was negative at ¥50,845,983.69, an improvement from negative ¥156,319,054.27 in Q1 2022[17] - The cash inflow from sales of goods and services was CNY 161,891,732.71, an increase of 42.4% from CNY 113,715,607.42 in Q1 2022[24] - The cash outflow for purchasing goods and services was CNY 165,867,576.89, a decrease of 27.0% compared to CNY 227,233,400.42 in Q1 2022[24] - The company reported a net decrease in cash and cash equivalents of -CNY 33,534,582.97 in Q1 2023, compared to an increase of CNY 15,451,741.73 in Q1 2022[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,444,493,776.32, a decrease of 4.89% from the end of the previous year[3] - The company's current assets totaled ¥964,883,739.11, down from ¥1,054,874,148.20, indicating a decrease of about 8.5%[9] - The total liabilities decreased to ¥449,747,274.45 from ¥523,781,745.43, representing a reduction of approximately 14.1%[11] - The company's total liabilities decreased to CNY 346,697,158.14 from CNY 396,830,216.11 at the end of 2022, reflecting a reduction of 12.6%[21] Research and Development - R&D expenses totaled ¥15,966,270.79, down 35.30% from the previous year, with R&D investment accounting for 10.34% of operating revenue, a decrease of 10.61 percentage points[3] - Research and development expenses decreased to ¥15,966,270.79 in Q1 2023 from ¥24,678,465.54 in Q1 2022, a reduction of 35.4%[13] - Research and development expenses for Q1 2023 were CNY 12,165,369.19, down 19.0% from CNY 15,063,524.33 in Q1 2022[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 4,247[6] - The largest shareholder, Wu Yaohua, holds 35.86% of the shares, totaling 26,057,910 shares[7] - The total equity attributable to shareholders was reported at ¥994,746,501.87, slightly down from ¥994,925,270.10, a decrease of about 0.02%[11] - The company's total equity increased slightly to CNY 993,969,398.17 from CNY 992,614,841.47 at the end of 2022[22] Operational Highlights - The company reported a significant increase in sales collections and a decrease in procurement costs, contributing to improved cash flow[4] - The company did not report any new product launches or significant market expansion strategies during this quarter[4] - The company has not disclosed any new product developments or market expansion strategies in the current report[12]